Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026)
Tilray Brands' (TLRY) quarterly Amortizatization of Intangibles came in at $19.3 million in Q2 2026, down 43.25% YoY from $34.1 million in Q2 2025, and up 860.8% on a QoQ basis from $2.0 million in Q1 2026.
Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 7 years of Amortizatization of Intangibles data on file, last reported at $19.3 million in Q2 2026.
- Quarterly Amortizatization of Intangibles fell 43.25% year-over-year to $19.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $38.9 million (down 45.65% YoY) and the FY2026 annual result came in at $67.6 million, down 49.36% from the prior year.
- Amortizatization of Intangibles rose to $19.3 million in Q2 2026, from $2.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $40.8 million in Q2 2022 to a low of $2.0 million in Q4 2025.
- A 5-year average of $21.5 million and a median of $29.9 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles slumped 91.51% — and 2024, when it rose 9.44%.
- Tracing TLRY's Amortizatization of Intangibles over 5 years: stood at $33.3 million in 2022, then slumped by 91.51% to $2.8 million in 2023, then rose by 3.18% to $2.9 million in 2024, then tumbled by 31.89% to $2.0 million in 2025, then soared by 872.89% to $19.3 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $19.3 million (Q2 2026), $2.0 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 516.11 Mn | 281.48 Mn | 90.52 Mn | 19.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 19.34 Mn |
| May 31, 2026 | 19.34 Mn |
| Feb 28, 2026 | 2.01 Mn |
| Feb 28, 2026 | 2.01 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Aug 31, 2025 | 15.56 Mn |
| Aug 31, 2025 | 15.56 Mn |
| May 31, 2025 | 34.08 Mn |
| May 31, 2025 | 34.08 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Aug 31, 2024 | 31.81 Mn |
| Aug 31, 2024 | 31.81 Mn |
| May 31, 2024 | 31.73 Mn |
| May 31, 2024 | 31.73 Mn |
| Feb 29, 2024 | 2.90 Mn |
| Feb 29, 2024 | 2.90 Mn |